Get a solution
ABOUT TIANQI
Established in Hunan on 27 September 2000 and quoted on China's National Equities Exchange and Quotations under stock code 837591, HUNAN-TECH NEW MEDICAL SYSTEMS CO.,LTD is a national high-tech enterprise integrating medical-device R&D, production, sales and technical services. For more than twenty years, it has specialised in microscopic-particle morphology and built original membrane-enrichment technology into products, instruments, digital analysis and technical services.
BUSINESS
Tianqi Medical began with the practical challenge of enriching pathogens for tuberculosis diagnosis. It independently developed an original membrane-enrichment pathogen-diagnosis technology that filled related technical gaps internationally and in China and achieved a fundamental methodological innovation in pathogen-enrichment testing. Continued development has made the technology a platform foundation for diverse samples, targets and downstream methods.
The company develops and produces membrane-enrichment diagnostic consumables, liquid-based sandwich cups for sputum smears, automated slide-preparation and reading equipment, and related product lines, connecting sample preparation, membrane enrichment, slide preparation, staining, microscopy and digital analysis.
For healthcare, disease prevention and control, life sciences, environmental monitoring and industrial testing, Tianqi Medical supplies products, supporting reagents and consumables, method configuration, after-sales support, and configured or batch delivery.
Technical services include laboratory-method training, guidance for standardised laboratory operations, equipment and workflow support, and digital slide-reading support, helping project teams connect products, methods and on-site processes.
Building on the extensibility of its core platform, the company delivers integrated microscopic-particle morphology solutions spanning sample collection and preparation, membrane enrichment, slide preparation and staining, microscopic observation, digital analysis and report integration.
Tianqi Medical has undertaken national science and technology projects and received provincial innovation-program support. As a national high-tech enterprise, it has obtained international quality-management-system certification and participates in industry-standard development, carrying its technology-, quality- and innovation-led approach through R&D, production and service.
Tuberculosis detection is an important origin of the company's technology. Today, Tianqi Medical applies its capabilities across a broader range of medical and non-medical settings while fulfilling its public-health responsibilities through a commercially sustainable business.
ENRICHMENT FIRST · DETECTION NEXT
The enriched membrane interface can connect to morphology, fluorescence, nucleic-acid and other methods as needed. Our technical team can explain how the platform fits the existing workflow and which product system carries it forward.